# Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd., Wuhan, China – FDA Inspections

Source: https://www.keypedia.com/companies/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/0e692896-3bde-46a7-95ed-e65be70624d2

> Inspection records and compliance data for Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. in Wuhan. 4 FDA inspections on record, 2 Form 483s, last inspected March 07, 2025.

---

## Details

- Name: Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
- FEI Number: 3010163919
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: No. 99 2nd Shendun Road, East Lake, Technology Development Zone
- City: Wuhan
- Country Name: China
- Address: No. 99 2nd Shendun Road, East Lake, Technology Development Zone, Wuhan, China
- Country: China

## Related Documents

- [483 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. - Unknown Date](https://www.keypedia.com/records/483/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/7abf56ab-62b7-4f30-9caf-408534202ff9) — source: FDA, date: Invalid Date
- [FDA Inspection 1267158 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. - 2025-03-07](https://www.keypedia.com/records/fda_inspections/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/7a9a647f-297d-4678-a79c-86ff6c4d4c14) — source: FDA, date: March 7, 2025
- FDA Inspection 1267158 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. - 2025-03-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2025
- [FDA Inspection 1106763 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. - 2019-06-14](https://www.keypedia.com/records/fda_inspections/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/74609adf-ece9-4277-b566-4662d5c86af5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2019
- [FDA Inspection 1032045 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. - 2017-09-15](https://www.keypedia.com/records/fda_inspections/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/1f0a551c-0bea-40b7-8a2c-5fa22d58b93c) — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2017
- [FDA Inspection 931632 - Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. - 2015-05-22](https://www.keypedia.com/records/fda_inspections/humanwell-puracap-pharmaceuticals-wuhan-co-ltd/cc2bb936-8bb9-4bcf-8a0f-84ef81171bff) — classification: No Action Indicated (NAI), source: FDA, date: May 22, 2015

## Related Companies

- [Kingkey MBC Life Technology Group Co., Ltd.](https://www.keypedia.com/companies/kingkey-mbc-life-technology-group-co-ltd/40cceb6c-350d-44d3-aeb4-9652b4e5c303)
- [Yabao Pharmaceutical Co., Ltd. Beijing](https://www.keypedia.com/companies/yabao-pharmaceutical-co-ltd-beijing/0abb3f06-8186-4497-83ba-1cd93ffce2a6)
- [Mayo Clinic PET Radiochemistry Facility](https://www.keypedia.com/companies/mayo-clinic-pet-radiochemistry-facility/6b2304d3-2e0e-4a40-9b2d-5a95a9a873cf)
- [Biologische Heilmittel Heel Gmbh](https://www.keypedia.com/companies/biologische-heilmittel-heel-gmbh/e163fb49-bc67-47e3-9482-f204f12aeb64)
- [Zep Inc](https://www.keypedia.com/companies/zep-inc/e2bf15a9-eb41-4970-8e7a-5e4be5f0ec72)
- [K Patel Phyto Extractions Private Ltd](https://www.keypedia.com/companies/k-patel-phyto-extractions-private-ltd/bbf009f3-31f6-4e6e-a120-33a1b50293cf)
- [ABC Compounding Co., Inc.](https://www.keypedia.com/companies/abc-compounding-co-inc/ffd26af1-9fee-4ed0-acf0-9a4ac91014c2)
- [Novo Nordisk Pharmaceutical Industries LP](https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/6bd6ea0d-568a-4f97-ba33-f6bbab29a175)
- [Vils Pharma Coating, LLC](https://www.keypedia.com/companies/vils-pharma-coating-llc/fafd512e-c895-4c48-92b7-b71a8c518d36)
- [CSL Plasma Inc.](https://www.keypedia.com/companies/csl-plasma-inc/5ba3e302-9206-4ced-97c5-64c8f2297c0b)

## Related Officers

- [National Expert, Pharmaceutical](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)